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The ubiquitous thioredoxin fold proteins catalyze oxida-
tion, reduction, or disulfide exchange reactions depending on
their redox properties. They also play vital roles in protein
folding, redox control, and disease. Here, we have shown that
a single residue strongly modifies both the redox properties of
thioredoxin fold proteins and their ability to interact with sub-
strates. This residue is adjacent in three-dimensional space to
the characteristic CXXC active site motif of thioredoxin fold
proteins but distant in sequence. This residue is just N-terminal
to the conservative cis-proline. It is isoleucine 75 in the case of
thioredoxin. Our findings support the conclusion that a very
small percentage of the amino acid residues of thioredoxin-re-
lated proteins are capable of dictating the functions of these
proteins.
The thioredoxin fold is the core scaffold of numerous pro-
teins that control disulfide redox activity in the cell (1–3). These
redox proteins share very little sequence homology, but all of
them incorporate the four-stranded -sheet, three flanking
-helices, and the redox-active CXXC motif of the TRX5 fold
(Fig. 1A). The archetype of the family is thioredoxin (4), a disul-
fide reductase thatmaintains a reducing cytosolic environment.
Other TRX fold redox proteins include the Dsb proteins (1),
which regulate the formation of disulfide bonds in prokaryotes,
and protein-disulfide isomerase (5), which catalyzes the oxida-
tion and shuffling of disulfides in the endoplasmic reticulum of
eukaryotic cells.
This wide range of redox activities of TRX fold proteins is
thought to be a consequence of modifications to the common
scaffold, which result in different redox properties. Thus, the
redox potential of Escherichia coli thioredoxin is very reducing,
at 271 mV (6, 7), whereas that of the oxidizing periplasmic
protein E. coliDsbA is120mV (8). Thioredoxin fold proteins
that participate in a wide range of thiol disulfide exchange reac-
tions, such as the eukaryotic protein-disulfide isomerases, have
intermediate redox potentials (around160 mV (9)).
Thioredoxin-related proteins provide an attractivemodel for
the study of how protein function is dictated by sequence and
three-dimensional structure; this is because their functions are,
in part, determined by their redox properties, which in turn, are
easy to quantify. For example, mutations in thioredoxin that
make its redox potential more oxidative complement null
mutations in the oxidase DsbA (10, 11). A detailed understand-
ing of how thioredoxin fold sequence affects redox properties
provides an excellent opportunity to relate sequence and func-
tion. Previous work has focused on the role of the CXXC “redox
rheostat” active site in determining the properties of thiore-
doxin-related proteins (3, 12, 13). Experiments that exchange
the X-X dipeptide of one thiol-disulfide oxidoreductase with
that of another generally result in an oxidoreductase with a
redox potential partially shifted in the direction of the oxi-
doreductase protein that served as the source of the dipeptide
(3, 12–14).
Although the X-X dipeptide is important, it is not the only
feature that influences thioredoxin fold protein function.
Another extremelywell conserved butmuch less studied region
of thioredoxin-like proteins is the loop containing a cis-proline,
which closely approaches the CXXC motif (5). Biophysical
studies of E. coli thioredoxin and DsbA indicate that the con-
served cis-proline residue plays a significant role in the stability
and structure of these proteins (16, 17). Other studies have
identified additional interesting roles for the cis-proline loop.
For example, mutation in E. coliDsbA of the cis-proline residue
causes accumulation ofmixed disulfide intermediates with sub-
strates in vivo (18), suggesting that the cis-proline plays a role in
substrate release. Furthermore, studies on human thioredoxin
revealed that its cis-proline prevents metal binding by the active
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site thiolates (19). Structural evidence from both thioredoxin and
DsbA indicates that the cis-proline loop is involved in substrate
binding (20–22). Finally,mutations in the residue justN-terminal
to the cis-proline (the cisPro-minus1 residue) in DsbG give rise to
variants that gained DsbC-like isomerase activity (23).
The side chain of the cisPro-minus1 residue is usually within
4 Å of the reactive N-terminal cysteine of the CXXC motif,
giving this residue the potential to be involved in hydrogen
bonding and hydrophobic interactions with the nucleophilic
cysteine and thereby to modulate its activity (see Fig. 1).
To investigate the role of the cisPro-minus1 residue, this
study tests the effect of mutations on the activities and redox
properties of thioredoxin fold proteins. We examined four
divergent members of the thioredoxin family: E. coli DsbA, a
strong oxidase; E. coli thioredoxin, which is relatively reducing;
E. coli DsbC a protein-disulfide isomerase; and E. coli DsbG, a
thioredoxin-related protein with redox properties similar to
those of the isomerase DsbC but with no known in vivo sub-
strates. The results show that the cisPro-minus1 residue is uni-
versally important in determining the redox properties of thi-
oredoxin fold proteins. It also seems to be crucial in regulating
the ability of these proteins to interact with both upstream and
downstream substrates.
EXPERIMENTAL PROCEDURES
Bacterial strains and plasmids used in the study are listed in
supplemental Table S1. Plasmid construction, site-directed
mutagenesis, protein purification, reduction, oxidation, con-
centration determination, and sequence alignment are
described in the supplemental “Experimental Procedures.”
Redox Potential Measurement—The redox potentials of wild
type (WT) DsbA, DsbG, DsbC, and their mutants and the thi-
oredoxin mutants CPHC and I75T/CPHC were measured by
incubation in degassed redox buffers containing various con-
centrations of GSH/GSSG, as described by Bessette et al. (24).
The redox potentials of thioredoxin and other mutants were
determined by redox equilibria with cDsbD, mainly as
described by Collet et al. (25). The redox potential of cDsbD
(241 mV) was used as a standard.
Determination of pKa Values—To determine the pH-
dependent ionization of the nucleophilic cysteine, we recorded
the specific absorbance of the thiolate anion at 240 nm (26).We
also monitored the pH-dependent absorbance of the oxidized
form as a reference. Measurements were carried out at 25 °C in
a buffer consisting of 10 mMK2HPO4, 10 mM boric acid, 10 mM
sodium succinate, 1 mM EDTA, and 200 mM KCl, pH 7.5, for
DsbA, DsbC, DsbG, and mutants, with an average initial pro-
tein concentration of 20M.The pHof the protein solutionwas
lowered to 2.2 by the stepwise addition of aliquots of 0.2 MHCl.
Absorbances at 240 and 280 nmwere recorded on aCary 50BIO
UV-visible spectrophotometer and corrected for the volume
increase. For thioredoxin and thioredoxin mutants, measure-
ments were carried out at 25 °C in a buffer consisting of 10 mM
NaH2PO4, 10mM sodium citrate, 10mM sodiumborate, pH 8.5.
The pH of the protein solution was lowered to 3 by the stepwise
addition of aliquots of 0.2 M HCl. Absorbances at 240 and 280
nm were recorded on a Cary 100BIO UV-visible spectropho-
tometer and corrected for the pH decrease and volume
increase. All buffers were degassed, and purged with nitrogen
before experiments. The pH dependence of the thiolate-
specific absorbance signal (S  (A240/A280)reduced/(A240/
A280)oxidized) was fit according to the Henderson-Hasselbach
equation.
ReductaseActivityAssay—The ability ofDsbA,DsbG, thiore-
doxin, DsbC, and variants to catalyze the reduction of human
insulin in the presence of DTT was tested essentially as
described by Holmgren (27). A stock solution of 872M insulin
was freshly prepared in 0.1 M potassium phosphate buffer, pH
7.0, and 2 mM EDTA before each assay. The reaction mixtures
were prepared directly in cuvettes using 0.1 M potassium phos-
phate buffer, pH 7.0, 2 mM EDTA, and 0.33mMDTTwith 5M
enzyme in a final volume of 0.8 ml. The reactions were started
by adding insulin to a final concentration of 131M. After thor-
ough mixing, the cuvettes were placed in the spectrophotome-
ter, and measurements were performed at 650 nm for 120 min.
In all experiments, the uncatalyzed reduction of insulin byDTT
was monitored in a control reaction without the addition of
thioredoxin-related oxidoreductases.
The ability of thioredoxin and variants to catalyze the
reduction of human insulin in the presence of thioredoxin
reductase and NADPH was tested as described by Lund-
stro¨m and Holmgren (28). The reaction mixtures were pre-
pared directly in cuvettes using 0.1 M potassium phosphate
buffer, pH 7.0, 2 mM EDTA, 0.2 mM NADPH, 0.1 M thiore-
doxin reductase, 5 M thioredoxin, and variants in a final
volume of 0.8 ml. The reactions were started by adding insu-
lin to a final concentration of 100 M.
TABLE 1
Sequence of the CXXCmotif and cisPro loop
The Sequences of each protein family surrounding CXXC and cis-proline were
compiled and used to generate sequence logos. The size of the amino acid single-
letter code is proportional to the occurrence of that amino acid at that position. To
determine the conservation of the residues in the CXXC and cis-proline loop in
these proteins, we analyzed the proteins from genomes that are as divergent as
possible; however, we wanted to avoid comparing proteins that have been evolving
over different evolutionary time frames. Thioredoxin and glutaredoxin, for instance,
are present in eukaryotes, bacteria, and archaea, and therefore have been evolving
for at least 3.8 billion years (53), whereas DsbC and DsbG are restricted to pro-
teobacteria and have probably been evolving for at least0.5 billion years (23, 53).
Thuswe restricted our comparison to genomes that contain an orthologue toDsbC.
We used our previous alignment of all species-specific DsbC sequences available in
GenBankTM (23) to obtain the list of organisms that contain DsbC. We then
obtained the sequence of the individual thioredoxin, DsbA, DsbG, and glutaredoxin
orthologues present in these individual genomes using blast by searchingwith the E.
coli homologue.
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Oxidase Activity Assay—The oxidative folding of hirudinwas
tested essentially as described by Quan et al. (11). In brief, oxi-
dase activity was determined by the rate at which oxidized
DsbA, DsbG, thioredoxin, or their variants donate a disulfide
bond to reducedhirudin. The fluorescence excitation at 295 nm
increases when oxidized DsbA, DsbG, or thioredoxin loses its
active site disulfide bond; however,
hirudin itself shows no fluorescence
changeduring the reaction.The assay
was performed on a KinTek SF-2004
stop flow instrument in single-mixing
mode. The traces consisted of a min-
imum of three to five successive stop
flow experiments, and the data for
each trace were fit individually to a
single exponential equation to obtain
the pseudo first-order rate constant
Kobs. AveragedKobs values were plot-
ted against thehirudin concentration.
The slope is the observed second-or-
der rate constant of the reaction,
which indicates the oxidase activity.
Isomerase Activity Assay with
Scrambled Hirudin as a Substrate—
Scrambled hirudin refolding was
tested essentially as described by
Hiniker et al. (23). Hirudin samples
were diluted to 24 M and incubated
withorwithout 24MreducedDsbA,
DsbG, thioredoxin, or their variants
in 100 mM sodium phosphate, 1 mM
EDTA,pH7.0.Foldingreactionswere
quenched by addition of 10% (v/v)
formic acid following incubation at
room temperature at various time
points. The reaction products were
separated by reverse-phase HPLC on
a VydacTM218TP54 C18 column at
55 °C using an acetonitrile gradient
(19–25%, 30 ml) in 0.1% (v/v) triflu-
oroacetic acid. The eluted proteins
were detected by their absorbance at
220 nm.
Refolding of Scrambled RNase A—
To determine the in vitro isomerase
activity of DsbA V150T and DsbC
T182V, we also utilized the scram-
FIGURE 1. A, schematic representation of the secondary structure elements of E. coli thioredoxin, DsbA, and
DsbC (DsbG has secondary structure elements similar to those of DsbC). The characteristic elements of the
thioredoxin fold (112 and342motifs linkedby a shorthelix (c)) are shown in violet, and insertions
in the thioredoxin fold are colored in gray. The positions of the CXXC catalytic motif and the cis-proline loop in
each protein are indicated. B, ribbon diagrams of the structures of E. coli DsbA (PDB code 1FVK (54)), the
thioredoxin domain of DsbC (oriented using DsbA as a reference; PDB code 1EEJ (39)), thioredoxin (PDB code
2TRX (55)), and thioredoxin I75T variant (PDB code 3DYR (this work)). The thioredoxin domains are shown in
violet, the inserted domains in gray, and the active site cysteines in a yellow space-filling representation. The
thioredoxin fold elements, CXXC and cis-proline loop, are labeled. C, active sites of E. coli DsbA, DsbC, thiore-
doxin, and thioredoxin I75T variant showing the catalytic CXXC motif and the cis-proline loop. The distances
between the sulfur of the N-terminal nucleophilic cysteine (Cys-30, Cys-98, and Cys-32 for DsbA, DsbC, and
thioredoxin, respectively) and the main chain oxygen of the cisPro-1 residue (Val-150, Thr-182, Ile-75, and
Thr-75 forDsbA,DsbC, thioredoxin, and thioredoxin I75T, respectively) are indicated. ForDsbCand thioredoxin
I75T, thedistances to thehydroxyl groupof Thr-182 andThr-75 are shown (for comparison, thedistances to the
CG1 atom of Ile-75 in thioredoxin and the CG2 of Val-150 in DsbA are also indicated). Hydrogen bonds are
represented by a thick black line. In the absence of a hydrogen bond, distances are shownwith a thin black line.
The cisPro-1 residue is labeled in green. This figure was generated using MacPyMOL (15).
TABLE 2
Parameters for DsbA, DsbG, thioredoxin, DsbC, and their variants
N.D., not determined. The lack of redox-dependent fluorescence in DsbC and its mutants means that these cannot be assayed for oxidase activity in this manner. The ‘’,
‘’ designations refer to ‘’ the best isomerase activity among all the proteins listed; ‘’ no detectable isomerase activity.
Protein Redox potential pKa Reductase Oxidase Isomerase
mV A1min2M1 M1s1
DsbA 120 2 3.3 0.1 1.74 0.06 104 1.76 0.12 
V150T 92 1 3.5 0.1 0.13 0.01 104 2.20 0.014 
DsbG 127 2 3.5 0.1 0.01 104 0.0043 0.0004 
T200L 178 4 N.D. 0.22 0.01 104 0.0043 0.0004 
T200Ma 181 3 N.D. 0.23 0.1 104 N.D. 
Thioredoxin 271 3 7.0 0.2 14.9 0.2 104 0.090 0.003 
I75T 226 2 5.5 0.2 33.1 0.3 104 0.123 0.004 
DsbC 143 2 4.6 0.1 27.6 104 N.D. 
T182V 195 2 5.8 0.1 33.9 104 N.D. 
a Parameters for DsbG T200M are from Hiniker et al. (23).
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bled RNase A refolding assay. Reduced denatured RNase A (0.5
mg/ml) was incubated in 50 mM Tris-HCl, pH 8.5, and 6 M
GdmCl for at least 3 days in the dark at room temperature to
prepare scrambled RNase A (29). The randomly reoxidized
RNase A was concentrated, and after acidifying the solution,
the oxidation of disulfide bonds was confirmed using Ellman’s
assay. Reshuffling of scrambled RNase A (40 M) was carried
out by incubation in 100 mM phosphoric acid-NaOH, pH 7, 1
mM EDTA, with 10 M oxidized DsbC, DsbCT182V, DsbA, or
DsbAV150T (DsbA,DsbC, andmutants were oxidizedwith 1.7
mM copper(II)[1,10-phenanthroline]). The reactions were
started by the addition ofDTT to a final concentration of 10M.
As a positive control, we carried out an additional reaction
using foldedRNaseAwithout any thioredoxin fold protein. The
assaywas performed at 25 °C, and samples were taken at several
time points and assayed for RNase A activity by monitoring
cCMPhydrolysis spectrophotometrically at 296 nm for 2.5min.
The fraction of native RNase A (%) was plotted against incuba-
tion time.
Kinetics of DsbA V150T Interaction with DsbB—Oxidation
of reduced DsbA and variants by DsbB and Q1 was tested
according to Tapley et al. (30). Briefly, a typical reaction
contained 100 M freshly reduced DsbA or V150T, 10 M
DsbB, and 200 M ubiquinone-1 (coenzyme Q1, Sigma).
DsbA and a DsbB/coenzyme Q1 mixture were incubated in
50 mM sodium phosphate, 300 mM NaCl, and 0.04% dodecyl
maltoside, pH 8.0, at 25 °C before mixing. The absorbance
after mixing was recorded at 510 nm. One data set contained
three to five successive injections, and data for each trace
were analyzed separately. The resulting data were further fit
using SigmaPlot and the Michaelis-Menten equation to give
Km and kcat values.
Spot Titers for Cadmium Resistance and Copper Resistance—
Spot titers for cadmium resistance were performed to quantify
the relative oxidase activity of DsbA and variants in vivo. Spot
titers for copper resistance were performed to quantify the rel-
ative reductase activity caused by mutations in thioredoxin in
vivo. Briefly, strains were grown overnight in LB-ampicillin
(200 mg/ml) and diluted 1:100 into fresh LB-ampicillin (200
mg/ml). Strains were grown to mid-logarithmic phase at 37 °C
and serially diluted into 150mMNaCl. 2l of each dilution was
plated onto LB-ampicillin plates (200 mg/ml) with 40 M cad-
mium (for oxidase assay) or TB plates with 17 mM CuCl2 (for
reductase assay) as described previously (23, 31); cells were
grown at 37 °C overnight. All spot titers were performed in
duplicate or triplicate.
4-Acetoamido-4-maleimidylstilbene2,2-disulfonicacid(AMS)
Trapping—Strains were grown overnight in LB-ampicillin (200
mg/ml) and diluted 1:100 into fresh LB-ampicillin (200 mg/ml).
Strains were grown to mid-logarithmic phase at 37 °C, and DsbA
ormutantproteinwereexpressedby inductionusing1mMisopro-
pyl 1-thio--D-galactopyranoside for 10min. Cells were acid-pre-
cipitated overnight equivalent to 0.5 OD units. Acid-precipitated
proteins were solubilized in buffered SDS solution containing 10
mg/ml AMS. The samples were incubated in the dark at 37 °C for
1 h. Alkylation was stopped by the addition of reducing SDS load-
ing buffer and analyzed by electrophoresis andWestern blotting.
Protein Structure Determination—Purified thioredoxin I75T
(15 mg/ml) was crystallized using sitting-drop vapor diffusion.
Crystals were grown in 30% polyethylene glycol 8000, 150 mM
sodium acetate, and 100 mM sodium cacodylate, pH 6.5. The
crystals belong to the C2 space group with unit cell dimensions
of a 58.8 Å, b 39.4 Å, c 90.6 Å, and  96.6°. There are
two molecules in the asymmetric unit. A 2.0 Å resolution data
set was collected using X-rays generated by a Rigaku rotating
anode x-ray generator. The structure was solved by molecular
replacement as implemented in the CNS program (32) using
theWT E. coli thioredoxin structure as a searchmodel (2TRX).
The model was initially refined using the CNS program (32)
with rebuilding in O (33) followed by refinement with Refmac5
(34) fromCCP4 suite (35) and finally in Phenix (36). TLS parame-
ters were incorporated during the refinement process. Each thi-
oredoxinmolecule in the asymmetric unit was defined as oneTLS
group. The final model has a working R-factor of 25.1% and a free
R-factor of 29.0%. The modest R-factors are largely because the
crystal used indata collectionwas slightly twinned.Data collection
and structure refinement statistics are shown in supplemental
Table S3.
RESULTS
The cisPro-minus1 Residue Regulates the Redox Potential of
Thioredoxin Fold Proteins—Sequence alignment of the various
subfamilies of thioredoxin fold proteins revealed that the cis-
Pro-minus1 residue tends to be conserved within each subfam-
ily but differs between different subfamilies (Table 1). Isoleu-
cine is common in thioredoxins, threonine is common in the
prokaryotic disulfide isomerases DsbC and DsbG, and valine is
common in DsbA and glutaredoxins. Given this pattern of con-
servation, the close proximity in three-dimensional space of
this residue to the active site (see Fig. 1) and the existence of
gain and loss of function mutations that affected this cisPro-
minus1 residue in DsbG (23), we were intrigued by the possi-
bility that the character of the cisPro-minus1 residue helps to
determine the divergent properties of the various subfamilies of
thioredoxin fold proteins. Thus, DsbA, DsbC, DsbG, and thi-
oredoxin cisPro-minus1mutants (Table 2)were constructed on
the basis of the simple principle of exchanging the side chain
common to one subfamily with that present in another subfam-
ily. For example, the cisPro-minus1 residue in the oxidaseDsbA
is nearly always valine; this was exchanged with threonine, the
residue most commonly found in the isomerases DsbC and
DsbG, to generate the variant DsbA V150T.
The redox potentials of the mutant proteins were measured
(Table 2, supplemental Fig. S1). When threonine replaces the
hydrophobic valine or isoleucine residue at the cisPro-minus1
position, the redox potential is substantially increased. Thus
threonine exerts amore oxidizing influence than valine. For the
DsbA V150T mutant, for instance, the equilibrium constant
with glutathione is 1.0 105 M. This translates to an intrinsic
redox potential (Eo) of92 mV. DsbA V150T is thus substan-
tially more oxidizing than WT DsbA, Keq  8.67  105 M,
Eo  120 mV, making it as oxidizing as DsbL (37), the most
oxidizing disulfide catalyst known. In contrast, when a hydro-
phobic side chain replaces the more hydrophilic threonine, as
in the DsbG T200L, DsbG T200M, or DsbC T182V mutants,
cis-Proline Loop Controls Thioredoxin Protein Activity
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the redox potential of proteins is substantially decreased. Thus
a hydrophobic residue at the cisPro-minus1 position exerts a
reducing influence on the protein (Table 2).
To further explore the effects of side chain substitutions at
the cisPro-minus1 position, we examined the effect of altering
this residue in thioredoxin (Ile-75) to all other possible amino
acid side chains. We characterized the mutants in vivo and in
vitro, as shown in supplemental Table S2 and Fig. 2. All substi-
tutions at the Ile-75 position alter the redox potential of the
thioredoxin (Fig. 2A). Every substitution made thioredoxin
more oxidizing, consistent with the idea that evolution has
maximized the reducing power of thioredoxin. These results
show that the cisPro-minus1 residue has a very strong influence
on the redox properties of thioredoxin proteins. Surprisingly,
these changes in redox potential are very similar in magnitude
to those within the active site CXXCmotif of thioredoxin, sug-
gesting that the cisPro-minus1 residue in thioredoxin fold pro-
teins has just as important a role in determining the redox
potential of these proteins as the comprehensively studied
CXXC residues (3, 11–14, 38). In contrast, substitutions in the
residue just C-terminal to the cis-proline (the cisPro-plus1
position) had very little effect on the redox properties of various
thioredoxin fold proteins (data not shown), leading to the con-
clusion that this residue is not important in determining the
redox properties of these proteins.
The crystal structures of thioredoxin fold proteins show that
the cis-proline loop and the X-X dipeptide interact with the
active site cysteines fromopposite directions (Fig. 1), raising the
possibility that they exert their influence independently of each
other. To explore this question, we combined two of the most
oxidizing thioredoxin mutations: the cisPro-minus1 I75T
mutation (Table 2) with the CPHC DsbA-like active site
sequence mutation (11) to generate the double mutant. The
double mutant has a redox potential of180 mV, 91 mVmore
oxidizing than the wild type and thus by far the most oxidizing
thioredoxin mutant that we know. Significantly, the increase in
the redox potential in the double mutant of 91 mV is almost
additive of the increases conferred by the individual mutations,
I75T (45 mV, Table 2) and CPHC (42 mV from supplemental
Fig S1C or 60 mV using the value from Ref. 10). These results
raise the interesting possibility that the majority of the redox
properties of thioredoxin fold proteins are determined by a very
small number of residues.
To further investigate what makes the thioredoxin I75T
mutant more oxidizing than WT thioredoxin, we solved the
crystal structure of the oxidized form of the protein to a reso-
lution of 2.0 Å (supplemental Table S3). The thioredoxin I75T
structure shows that themutation has little effect on the overall
structure of the protein; the root mean square deviation to the
wild type protein structure is 0.51 Å (Fig. 1B, supplemental Fig.
S4). However, the I75T substitution positions the hydroxyl
group of Thr-75 within hydrogen bond distance (3.4 Å) of the
nucleophilic Cys-33 sulfur (Fig. 1C). This hydrogen bond is
absent in WT thioredoxin, as the isoleucine side chain at posi-
tion 75 lacks an electronegative oxygen or nitrogen atom. Inter-
estingly, hydrogen bonds with the equivalent nucleophilic cys-
teines are observed in DsbC (39) and DsbG (40) structures (Fig.
1C) and have been proposed to be partially responsible for the
oxidizing redox potential of these isomerases (40). These obser-
vations suggest that a small change in the local environment of
the CXXC motif contributes to the dramatic change in the
redox properties of the variant. This is substantiated by our
analysis of the pKa values of the active site nucleophilic cysteine
of the thioredoxin fold variants. In most cases, mutation of the
FIGURE 2. In vitro and in vivo characterization of thioredoxin Ile-75 vari-
ants. The variants are listed as shown in the bottom of each panel. A, redox
potentials of thioredoxin andmutants except for the I75C and I75P mutants.
Reduced I75C and I75P are too rapidly oxidized by air to allow for an accurate
measurement of redox potential. B, in vitro reductase activity of thioredoxin
andmutants, insulin reduction activity usingDTT as the reducing source.C, in
vitro reductase activity of thioredoxin andmutants, insulin reduction activity
using NADPH with thioredoxin reductase as the reducing source. D, in vivo
reductase activity of thioredoxin and mutants as measured by copper sensi-
tivity. The gradient indicates a serial dilution of trxA null cells harboring thi-
oredoxin and its variants (from 1 to 106 OD).
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cisPro-minus1 residue resulted in changes in the pKa values of
the nucleophilic cysteine, and in some cases these changes were
substantial (Table 2). In general our data agree with previous
observations suggesting that as the pKa of the nucleophilic cys-
teine is lowered the disulfide bond becomes easier to reduce,
increasing the intrinsic redox potential of the protein (38). In
the case of the oxidase DsbA, replacement of WT Val by Thr
had little effect on the pKa (3.3  0.1 and 3.5  0.1, respec-
tively), despite the considerable difference in redox potential of
the two proteins (Table 2, supplemental Fig. S1G). A value of
3.3–3.5 for the pKamay represent a lower limit ofmeasurement
when using this method.
The cisPro-minus1 Residue Influences in Vitro Enzyme
Activity—Redox potential is a thermodynamic measure of the
redox properties of a protein. To determinewhether the cisPro-
minus1 residue contributes to redox function, we analyzed the
ability of the thioredoxin fold mutants to participate in thiol
exchange reactions by measuring their ability to reduce disul-
fides, oxidize cysteines, and isomerize incorrect disulfide
bonds.
Perhaps themost widely used kinetic assay for thiol-disulfide
oxidoreductases is measurement of the rate at which these pro-
teins accelerate the reduction of disulfides in insulin (27). We
initially used DTT as the electron donor in this assay, which
allowed a direct comparison of the reductase activity of the
cisPro-minus1 variants in DsbA, DsbG, DsbC, and thioredoxin.
As shown in Figs. 3A and 2B and supplemental Fig. S2A, muta-
tion of the cisPro-minus1 residue in DsbA, DsbC, DsbG, and
thioredoxin significantly affects the reductase activity of these
proteins, confirming the key role this residue plays in redox
enzymatic activity. In the case of Dsb proteins, the cisPro-mi-
nus1 modification affected the reductase activity in ways that
reflected changes in the redox potential (see Table 2). Thus,
DsbAV150T has a substantiallymore oxidizing redox potential
and, not surprisingly, is less efficient in reducing insulin. The
cisPro-minus1mutants of DsbC andDsbG aremore efficient in
reducing insulin, in keeping with their more reducing redox
potentials.
Surprisingly, about half of the 19 thioredoxin variants are
more active than WT thioredoxin in accelerating DTT-medi-
ated insulin reduction, some spectacularly so. Yet all thiore-
doxin mutants have more oxidizing redox potentials than the
WT enzyme. Generally, mutations have a detrimental effect on
activity of proteins; sophisticated directed evolution experi-
ments are generally required to isolate proteins with enhanced
activity (41, 42). Thus the observation that many of the muta-
tions in the thioredoxin cisPro-minus1 residue have improved
activity inDTT-mediated insulin reduction is striking.Mutants
that exhibit higher activity thanWT thioredoxin can be divided
into two groups according to the properties of their cisPro-
minus1 side chains. The mutants in group I, where Ile-75 is
exchanged for another large hydrophobic group such as Phe,
Leu, Met, or Val have redox potentials similar to WT (257 to
270 mV versus271 mV) (supplemental Table S2) but show
very large increases in DTT-mediated insulin reduction. The
mutants in group II (I75C, I75S, and I75T) have a free hydroxyl
or thiol group in the side chain of the cisPro-minus1 residue and
so can potentially interact with the active site cysteines. These
group II variants also show large increases in DTT-mediated
insulin reduction activity, despite their more oxidizing redox
potentials (supplemental Table S2). Interestingly, the thiore-
doxin variant I75Y, which has an aromatic ring and a free
hydroxyl, apparently shows the effects of both groups I and II, as
it has a 30-fold increase in DTT-mediated insulin reduction
activity compared with WT thioredoxin. In all, seven substitu-
tions at the cisPro-minus1 position had activity	250% of WT
thioredoxin in this assay. On the other hand, charged residues
at this position had decreased activity, with I75D and I75E com-
pletely inactive.
We also measured the oxidase activity of the proteins by
looking at the rate at which the variant proteins donate their
disulfide bond to substrates like hirudin. A disulfide donation
step is one of several reactions that need to occur during enzy-
matic thiol-disulfide oxidoreductase reaction cycles. None of
the mutants significantly altered the rate of this reaction step
(Fig. 3B), which implies that alterations in the kinetics of other
steps in the reaction cycle, such as the oxidation of DsbA by
insulin, are more important in explaining the changes in enzy-
matic activity seen in DTT-mediated insulin reduction.
Isomerase activity requires the ability of enzymes to reduce
mismatched protein disulfides and subsequently form correct
disulfides; this requires both reductase and oxidase activity. As
the oxidase activity of the cisPro-minus1 variants was essen-
tially unaltered compared with the WT thioredoxin fold pro-
teins, it is not surprising that the isomerase activity of the vari-
ants was altered in the same way as their reductase activity (Fig.
3C and supplemental Fig. S2). DsbC T182V showed a slightly
increased reductase activity but showed greatly decreased
isomerase activity (supplemental Fig. S2B). We predicted that
T182V would have decreased oxidase activity compared with
WT based on its redox potential and pKa. This case provides a
further indication that both reductase and oxidase activity con-
tribute to the ability of a protein to function as an isomerase.
The cisPro-minus1 Residue Is Involved in Interactions with
Upstream Partner Proteins—We also investigated the role of
the cisPro-minus1 residue in contributing to interactions with
partner proteins. One way to do this is by studying the in vivo
phenotype ofDsbAV150T and its ability to be reoxidized by the
membrane protein DsbB (Fig. 4) (43). Negatively influencing
the interaction between DsbA and its downstream substrates
(partially folded proteins) or its upstream partner (DsbB)
should impair disulfide bond formation in vivo so that the in
vivo effects would be similar to those seen in dsbA strains. For
example, dsbA strains are sensitive to cadmiumbecause of the
high affinity of Cd2 for protein thiol groups (11, 44). Similarly,
E. coli-expressing DsbA V150T is cadmium-sensitive (Fig. 4B)
showing that the cisPro-minus1 residue is important for in vivo
DsbA function. Given that DsbA V150T is equivalent to WT
DsbA (Fig. 4B) in oxidizing downstream substrates such as
hirudin, at least in vitro, it is possible that the in vivo phenotype
is a result of reduced affinity of DsbA V150T for its upstream
partner DsbB. Supporting this explanation, the Km for interac-
tion with DsbB is 5-fold higher for the V150T variant than for
WT DsbA (98 versus 16 M) (Fig. 4D). Similarly, the variant
DsbA V150G is 40-fold slower than WT DsbA in the rate at
which it is reoxidized by DsbB (10). Moreover, the DsbG
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T200L mutant is reduced only very slowly by its upstream
partner, DsbD (supplemental Fig. S3C). Thus, mutation of
the cisPro-minus1 residue in both DsbA and DsbG appears
to result in a defect in the interaction with their respective
upstream partners.
We also investigated the interaction of the thioredoxin cis-
Pro-minus1 variants with their upstream partner by testing the
ability of the variants to reduce insulin in the presence of their
physiological reductant, thioredoxin reductase, rather than
DTT. Once again, the cisPro-minus1 residue strongly affected
the rates of insulin reduction (Fig. 2C and supplemental Fig.
S3B). In many cases the activities paralleled those obtained
using DTT as the reductant (compare Fig. 2, panels B and C).
However, in some cases the variants have the opposite effect on
activity. For instance, the thioredoxin I75Y variant, which was
so spectacularly active in DTT-dependent insulin reduction
(Fig.2B),wasalmostcompletelyinactiveinthioredoxinreductase-
dependent insulin reduction (Fig. 2C), suggesting that the cis-
Pro-minus1 residue affects the interaction with the reductant.
E. coli thioredoxin null mutant strains are Cu2-sensitive
due to their inability to keep DsbD reduced (31, 45). Thus, cop-
per sensitivity can be used to monitor in vivo reductase activity
of thioredoxin and its variants.We examined the in vivo activity
of the thioredoxin cisPro-minus1 variants bymeasuring copper
sensitivity. Cells expressing these mutants are all more copper-
sensitive than cells expressingWT thioredoxin (Fig. 2D). These
results suggest that in thioredoxin, as well as in DsbA and
DsbG, the nature of the cisPro-minus1 residue affects interac-
tion with upstream partner proteins and that this residue has
been optimized by evolution.
DISCUSSION
Nature often uses the same scaffold in functionally related pro-
teins andmodifies the common architecture to give rise to differ-
ent functionalities. One case that exemplifies this process is the
thioredoxin fold protein family. Proteins within this family share
only limited sequencehomology, yet theyhavea remarkable struc-
tural resemblance (1) and a broad range of redox activities. This is
achieved in part through the identity of residues in theX-X dipep-
tide between the catalytic cysteines of the conserved CXXCmotif
(13, 46).
The redox modulating effect of the X-X residues prompted
us to investigate another highly conservedmotif: the cis-proline
loop, which is distant in linear sequence but very close in space
to the CXXC active site motif. We found that the residue that
precedes the cis-proline is at least as important in determining
the redox properties of thioredoxin fold proteins as the well
studied CXXC motif. In addition, the cisPro-minus1 residue
seems to be vital for regulating the ability of the proteins to
interact with both upstream and downstream substrates. The
FIGURE3. In vitroactivityassays forDsbA,DsbG,and thioredoxin cisPro-1
variants. A, reductase activity was assayed using insulin and DTT as sub-
strates for DsbA (black), DsbG (red), and thioredoxin (blue) (same in B and C).
The orange line shows theDTT-only control. WT proteins are shownwith solid
lines and cisPro-1mutantswith dashed lines, sample names are as indicated in
the panels. B, oxidase activity was assayed using reduced hirudin as a sub-
strate. C, isomerase activity was assayed with scrambled hirudin as a sub-
strate. The scrambledhirudin startingmaterial is shown in Fig. S2C. Equimolar
quantities of reduced proteins and scrambled hirudin were incubated for 30
min for theDsbAand thioredoxin samples and18h for theDsbGsamples. The
reactions were then acid-quenched, and samples were analyzed by reverse-
phase HPLC on a VydacTM218TP54 C18 column. N and R indicate native and
reduced hirudin, respectively.
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choice of the cisPro-minus1 residue in any specific thioredoxin
fold protein appears to represent an evolutionary compromise
across all of these factors, allowing optimal activity of an indi-
vidual thioredoxin-family member.
On the basis of the comprehensive study reported here, we
can conclude that the cisPro-minus1 residue plays a key role in
controlling the activity of thioredoxin fold proteins in part by
modifying the active site cysteine reactivity. In all of the known
structures of thioredoxin fold proteins, this residue appears to
interact with the active site cysteine either via hydrogen dona-
tion or hydrophobic interaction. This is best illustrated when
the cisPro-minus1 residue is threonine. Thus, the crystal struc-
ture of thioredoxin I75T indicates the presence of a hydrogen
bond between the threonine and the active site cysteine that is
absent in the WT structure (Fig. 1). This hydrogen bond is
predicted to be stronger in the reduced form because the dis-
tance between cisPro-minus1 and the active site cysteine (as
determined from the structures of oxidized and reducedDsbG)
is optimal in the reduced form. The presence of the Thr likely
stabilizes the reduced form of the protein by formation of a
hydrogen bond with the thiolate and destabilizes the oxidized
form through electrostatic and steric interactions with the cys-
tine. This is measurable as a decrease in the pKa of the nucleo-
philic active site cysteine and an increase in the redox potential,
thereby favoring oxidase activity (26, 38, 47). At the same time,
threonine may favor more rapid kinetics, as shown by the sub-
stantial increase in the rate atwhich threoninemutation at cisPro-
minus1 in thioredoxin catalyzes DTT-dependent insulin reduc-
tion. This may explain why threonine is so commonly found in
prokaryotic disulfide isomerases yet is absent in reductases (Table
1). Similar effects on redox properties have been reported previ-
ously for Staphylococcus aureusDsbA, which naturally contains a
threonine in the cisPro-minus1 position; mutation of this Thr to
Val dramatically increases the pKa of the nucleophilic cysteine
from3.4 to 5.2 (48).Moreover, a recent bioinformatics studyhigh-
lighted the potential importance of threonines in modifying the
pKa of nearby cysteines in proteins (49).
Thioredoxin fold proteins transfer disulfide bonds from one
substrate to another. These proteins often have a wide range of
partially folded proteins that serve as downstream substrates
and usually just one upstream partner. For instance, the
upstream partner of thioredoxin is thioredoxin reductase; for
DsbA it is DsbB; and for DsbC (and DsbG) it is DsbD. Several
crystal structures of disulfide-linked complexes of thioredoxin
fold proteins with downstream and upstream partners have
recently been reported. These include thioredoxinBASI,
DsbADsbB, and thioredoxinthioredoxin-reductaseferredoxin
(20–22, 50). In all of these studies, the side chains of the cis-
proline loop residues are oriented toward the substrate, imply-
ing a role in substrate interaction. By altering the cisPro-minus1
residue, we have shown that it is surprisingly easy to improve
the activity of thioredoxin fold proteins toward their down-
stream substrates. However, none of the variants improved the
interaction with specific upstream partners, and most of them
negatively affected this interaction. This finding implies that the
cisPro-minus1 residue is important in the interaction of thiore-
doxin fold proteins with upstream partners and that the selection
of this residue may represent a compromise between optimal
redox properties and optimal substrate interactions. For example
WT E. coli DsbA has a valine at the cisPro-minus1 residue, even
though a threonine at this positionwouldmake itmore oxidizing.
Valine may allow a balance between the ability of E. coli DsbA to
oxidize substrates and to be oxidized by E. coliDsbB.
Structural data (20–22) indicate that thioredoxin fold
proteins recognize their partner proteins in part by forming
a transient antiparallel -sheet interaction with residues of
FIGURE 4. Characterization of DsbA andmutant V150T-DsbB interaction
in vivo and in vitro. A, E. coli disulfide bond formation pathway in the
periplasm. B, DsbA null mutants are very sensitive to cadmium. In vivo DsbA
oxidase activitywas examinedbymeasuring the cadmium resistanceofDsbA
null mutant strains expressing various mutants of DsbA on a plasmid. Spot
titerswere performedon LBplateswith 40M cadmium.C33S, represents the
DsbA active site mutant of CXXS. C, an acid trapping assay shows the slow
oxidation of DsbA V150T by DsbB in vivo. Expression of DsbA and mutants
was induced 10min before AMS acid trapping. Reduced DsbA shows a 1-kDa
upshift on SDS-PAGE. D, in vitro measurement of Km and kcat of DsbB cata-
lyzing the oxidation of DsbA and variants bymulti-turnover assay. The curves
were fit from the average of three independent experiments. Original data
are shown in supplemental Fig. S3A.
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the cis-Pro loop. To allow this interaction to occur, the cis-
Pro loop must be able to adopt a -strand conformation, and
steric clashes between the residues of the two strands must
be avoided. Independent biophysical modeling studies have
consistently shown that Asp is a nonfavored residue for
-strand structure (51, 52), so this residue in the cisPro-
minus1 position would be predicted to be deleterious for
activity of thioredoxin fold proteins. Consistent with this
prediction, we found that introducing Asp or Glu at the cis-
Pro-minus1 position of thioredoxin (I75D and I75E) com-
pletely abolished oxidoreductase activity in vivo and in vitro
(Fig. 2, C andD). Similarly, DsbAV150E had no significant in
vivo oxidase activity (data not shown). These results are also
consistent with sequence alignments of thioredoxin fold
proteins showing the complete absence of charged residues
at this cisPro-minus1 position.
In conclusion, the present study finds that the cisPro-mi-
nus1 residue is a general activity regulator of thioredoxin
fold proteins. It appears to control the activity of thiore-
doxin-family proteins by affecting both their redox proper-
ties and their ability to interact with partner proteins. These
findings provide insight into the relationship between the
thioredoxin fold structure and its function. They also high-
light a functional regulator that is distinct from the well
studied CXXC redox rheostat. This knowledge expands our
scientific understanding of this important class of proteins.
Furthermore, modification of the cisPro-minus1 residue
could lead to the development of thioredoxin fold proteins
with a range of redox activities that will be applicable in
industrial or academic settings, for example, in the in vitro
oxidative folding of protein substrates.
Acknowledgments—We thank members of the Bardwell, Jakob, and
Martin laboratories for helpful discussions. We also thank Tim Tap-
ley and Shu Quan for supplying protein samples for this study.
REFERENCES
1. Heras, B., Kurz, M, Shouldice, S. R., and Martin, J. L. (2007) Curr. Opin.
Struct. Biol. 17, 691–698
2. Martin, J. (1995) Structure 3, 245–250
3. Pan, J., and Bardwell, J. C. (2006) Protein Sci. 15, 2217–2227
4. Holmgren, A., Johansson, C., Berndt, C., Lo¨nn, M. E., Hudemann, C., and
Lillig, C. H. (2005) Biochem. Soc. Trans. 33, 1375–1377
5. Gruber, C., Cemazar, M., Heras, B., Martin, J. L., and Craik, D. J. (2006)
Trends Biochem. Sci. 31, 455–464
6. Krause, G., Lundstro¨m, J., Barea, J. L., Pueyo de la Cuesta, C., and
Holmgren, A. (1991) J. Biol. Chem. 266, 9494–9500
7. Lin, T., and Kim, P. S. (1989) Biochemistry 28, 5282–5287
8. Zapun, A., Bardwell, J. C., and Creighton, T. E. (1993) Biochemistry 32,
5083–5092
9. Appenzeller-Herzog, C., and Ellgaard, L. (2008) Biochim. Biophys. Acta
1783, 535–548
10. Jonda, S., Huber-Wunderlich,M.,Glockshuber, R., andMo¨ssner, E. (1999)
EMBO J. 18, 3271–3281
11. Quan, S., Schneider, I., Pan, J., Von Hacht, A., and Bardwell, J. C. (2007)
J. Biol. Chem. 282, 28823–28833
12. Mo¨ssner, E., Huber-Wunderlich, M., and Glockshuber, R. (1998) Protein
Sci. 7, 1233–1244
13. Huber-Wunderlich, M., and Glockshuber, R. (1998) Folding Des. 3,
161–171
14. Woycechowsky, K., and Raines, R. T. (2008) Biochemistry 42, 5387–5394
15. DeLano, W. L. (2002) The PyMOL Molecular Graphics System, DeLano
Scientific, San Carlos, CA
16. Georgescu, R., Li, J. H., Goldberg, M. E., Tasayco, M. L., and Chaffotte,
A. F. (1998) Biochemistry 37, 10286–10297
17. Charbonnier, J., Belin, P., Moutiez, M., Stura, E. A., and Que´me´neur, E.
(1999) Protein Sci. 8, 96–105
18. Kadokura, H., Tian, H., Zander, T., Bardwell, J. C., and Beckwith, J. (2004)
Science 303, 534–537
19. Su, D., Berndt, C., Fomenko, D. E., Holmgren, A., and Gladyshev, V. N.
(2007) Biochemistry 46, 6903–6910
20. Maeda, K., Ha¨gglund, P., Finnie, C., Svensson, B., andHenriksen, A. (2006)
Structure (Lond.) 14, 1701–1710
21. Inaba, K., Murakami, S., Suzuki, M., Nakagawa, A., Yamashita, E., Okada,
K., and Ito, K. (2006) Cell 127, 789–801
22. Dai, S., Friemann, R., Glauser, D. A., Bourquin, F., Manieri, W., Schu¨r-
mann, P., and Eklund, H. (2007) Nature 448, 92–96
23. Hiniker, A., Ren, G., Heras, B., Zheng, Y., Laurinec, S., Jobson, R. W.,
Stuckey, J. A., Martin, J. L., and Bardwell, J. C. (2007) Proc. Natl. Acad. Sci.
U. S. A. 104, 11670–11675
24. Bessette, P., Cotto, J. J., Gilbert, H. F., and Georgiou, G. (1999) J. Biol.
Chem. 274, 7784–7792
25. Collet, J., Riemer, J., Bader, M.W., and Bardwell, J. C. (2002) J. Biol. Chem.
277, 26886–26892
26. Nelson, J. W., and Creighton, T. E. (1994) Biochemistry 33, 5974–5983
27. Holmgren, A. (1979) J. Biol. Chem. 254, 9627–9632
28. Lundstro¨m, J., and Holmgren, A. (1990) J. Biol. Chem. 265, 9114–9120
29. Hillson, D. A., Lambert, N., and Freedman, R. B. (1984)Methods Enzymol.
107, 281–294
30. Tapley, T., Eichner, T., Gleiter, S., Ballou, D. P., and Bardwell, J. C. (2007)
J. Biol. Chem. 282, 10263–10271
31. Hiniker, A., Collet, J. F., and Bardwell, J. C. (2005) J. Biol. Chem. 280,
33785–33791
32. Bru¨nger, A., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-
Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read,
R. J., Rice, L. M., Simonson, T., andWarren, G. L. (1998) Acta Crystallogr.
Sect. D Biol. Crystallogr. 54, 905–921
33. Jones, T., Zou, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta Crys-
tallogr. Sect. A 47, 110–119
34. Murshudov, G., Vagin, A. A., and Dodson, E. J. (1997) Acta Crystallogr.
Sect. D Biol. Crystallogr. 53, 240–255
35. Collaborative Computational Project, Number 4 (1994) Acta Crystallogr.
Sect. D Biol. Crystallogr. 50, 760–763
36. Adams, P., Grosse-Kunstleve, R. W., Hung, L. W., Ioerger, T. R., McCoy,
A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., and
Terwilliger, T. C. (2002) Acta Crystallogr. Sect. D Biol. Crystallogr. 58,
1948–1954
37. Grimshaw, J. P., Stirmann, C. U., Brozzo, M. S., Malojcic, G., Gru¨tter,
M. G., Capitani, G., and Glockshuber, R. (2008) J. Mol. Biol. 380, 667–680
38. Grauschopf, U., Winther, J. R., Korber, P., Zander, T., Dallinger, P., and
Bardwell, J. C. (1995) Cell 83, 947–955
39. McCarthy, A., Haebel, P. W., To¨rro¨nen, A., Rybin, V., Baker, E. N., and
Metcalf, P. (2000) Nat. Struct. Biol. 7, 196–199
40. Heras, B., Edeling, M. A., Schirra, H. J., Raina, S., and Martin, J. L. (2004)
Proc. Natl. Acad. Sci. U. S. A. 101, 8876–8881
41. Hibbert, E., and Dalby, P. A. (2005)Microb. Cell Fact. 4, 29
42. Johannes, T., and Zhao, H. (2006) Curr. Opin. Microbiol. 9, 261–267
43. Ritz, D., and Beckwith, J. (2001) Annu. Rev. Microbiol. 55, 21–48
44. Vallee, B., and Ulmer, D. D. (1972) Annu. Rev. Biochem. 41, 91–128
45. Rietsch, A., Belin, D., Martin, N., and Beckwith, J. (1996) Proc. Natl. Acad.
Sci. U. S. A. 93, 13048–13053
46. Chivers, P. T., Laboissiere, M. C., and Raines, R. T. (1996) EMBO J. 15,
2659–2667
47. Shaked, Z., Szajewski, R. P., andWhitesides, G.M. (1980)Biochemistry 19,
4156–4166
48. Heras, B., Kurz, M., Jarrott, R., Shouldice, S. R., Frei, P., Robin, G.,
Cemazar, M., Tho¨ny-Meyer, L., Glockshuber, R., and Martin, J. L. (2008)
J. Biol. Chem. 283, 4261–4271
49. Salsbury, F. R. Jr., Knutson, S. T., Poole, L. B., and Fetrow, J. S. (2008)
cis-Proline Loop Controls Thioredoxin Protein Activity
10158 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 284•NUMBER 15•APRIL 10, 2009
 at UQ Library on October 9, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Protein Sci. 17, 299–312
50. Malojcic´, G., Owen, R. L., Grimshaw, J. P., and Glockshuber, R. (2008)
FEBS Lett. 582, 3301–3307
51. Street, A., and Mayo, S. L. (1999) Proc. Natl. Acad. Sci. U. S. A. 96,
9074–9076
52. Kallberg, Y., Gustafsson, M., Persson, B., Thyberg, J., and Johansson, J.
(2001) J. Biol. Chem. 276, 12945–12950
53. Hahn, J., and Pat, H. (1986) Syst. Appl. Microbiol. 7, 178–183
54. Guddat, L., Bardwell, J. C., Glockshuber, R., Huber-Wunderlich, M.,
Zander, T., and Martin, J. L. (1997) Protein Sci. 6, 1893–1900
55. Katti, S. K., LeMaster, D. M., and Eklund, H. (1990) J. Mol. Biol. 212,
167–184
cis-Proline Loop Controls Thioredoxin Protein Activity
APRIL 10, 2009•VOLUME 284•NUMBER 15 JOURNAL OF BIOLOGICAL CHEMISTRY 10159
 at UQ Library on October 9, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
SUPPLEMENTAL DATA
SUPPLEMENTAL FIGURE LEGENDS
Fig. S1. Redox potential and pKa measurements. (A-D) Redox potentals of DsbA and its 
mutants, DsbG and its mutants, DsbC and its mutants, and thioredoxin mutants CPHC and 
I75T/CPHC were measured in GSH-GSSG redox buffer. The redox states of DsbA and its 
mutants, DsbG and DsbG T200L, were followed by the detection of fluorescence emission at 
330 nm (excitation at 295 nm). The redox status of DsbC and its mutants was examined by 
reverse phase HPLC. The two thioredoxin mutants had reduced and oxidized peaks that could 
not be fully separated from the reduced peak of cDsbD in HPLC analysis and thus could not 
be measured using cDsbD as a reference. DsbA (■), DsbA V150T (□), DsbG () and DsbG 
T200V (), thioredoxin CPHC () and I75T/CPHC (r)，and DsbC (◆) and DsbC T182V 
(◇). (E-F) Redox potentials of thioredoxin and mutant I75T were analyzed by determining the 
equilibrium between thioredoxin and the C-terminal domain of DsbD (cDsbD) using 
reverse-phase HPLC. (G-J) Determination of the pKa of the nucleophilic cysteine in DsbA (■), 
DsbA V150T (□), DsbG () and DsbG T200V (), thioredoxin () and thioredoxin I75T 
(r)，and DsbC (◆) and DsbC T182V (◇). The pH dependence of the thiolate-specific 
absorbance signal (S = (A240/A280)reduced/(A240/A280)oxidized) was fit according to the 
Henderson-Hasselbach equation (the oxidized proteins were used as a reference). For DsbA 
V150T, no significant change in pKa was detected.  This finding is inconsistent with the 
observation that this mutant is substantially more oxidizing than wild-type DsbA. We note 
that it may not be possible to accurately measure pKa values below about 3.5 due to the 
previously noted interference of protein denaturation at low pH values (1).
Fig. S2. In vitro reductase and isomerase activity assays for DsbA and DsbC cisPro 
minus 1 variants. (A) Reductase activity was assayed using insulin and DTT as substrates for 
DsbC. (B) Refolding of scRNaseA was carried out by incubating the scrambled RNase A 
enzyme (40 µM) in 100 mM sodium phosphate/NaOH, pH 7.0, 1 mM EDTA, 10 mM DTT 
and in the presence of 10 µM DsbA() or DsbA V150T() and DsbC(<) or DsbC T182V 
(¨). Folded RNase was used as a positive control (p). The cleavage of cCMP by native 
RNase A was followed spectroscopically at 296 nm. (C) Control isomerase assay in the 
absence of any disulfide oxidoreductase catalyst with scrambled hirudin as a substrate. Equal 
molar quantities of GSH and scrambled hirudin were incubated for various times, as indicated 
in the figure. The reactions were then acid quenched and analyzed by reverse-phase HPLC on 
a Vydac™218TP54 C18 column. N and R indicate native and reduced hirudin, respectively.
Fig. S3. Characterization of DsbA-DsbB, thioredoxin-thioredoxin reductase and 
DsbG-DsbD interactions. (A) In vitro measurement of Km and kcat for DsbB-mediated 
catalysis of DsbA and V150T oxidation using the multi-turnover assay. Traces 1-3 and 4-6 
represent the three repeated experimental trials for DsbA and V150T, respectively. The traces 
were used to derive a V versus [S] plot (shown in Fig. 3D) using the enzyme-monitored 
turnover method. (B) Thioredoxin reductase based thioredoxin and I75T of insulin reduction 
activity were measured using NADPH as the reducing source. The inset panel shows insulin 
reduction protein in the presence of increasing thioredoxin reductase concentrations. (C) 
Reduction of 1 μM oxidized DsbG and its variants by 1 μM cDsbD when 10 nM nDsbD was 
added to the system. 
Fig. S4. Root-mean-square difference between the structures of wild-type thioredoxin and 
I75T. Shown here is a plot of rmsd for c alpha carbon atoms between the two structures versus 
the residue number of the primary sequence.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Sequence alignment
In order to determine the conservation of the residues in the CXXC and the cis-proline loop in 
these proteins, we aimed to analyze proteins from genomes that are as divergent as possible. 
However, we wanted to avoid comparing proteins that evolved over different evolutionary 
timeframes. Thioredoxin and glutaredoxin, for instance, are present in eukaryotes, bacteria 
and archaea, and therefore have been evolving for at least 3.8 billion years (2), whereas DsbC 
and DsbG are restricted to proteobacteria and have probably been evolving for at least ~0.5 
billion years (3). Thus, we restricted our comparison to genomes that contain an orthologue to 
DsbC. We used our previous alignment of all species-specific DsbC sequences available in 
GenBank(3) to obtain the list of organisms that contain DsbC. We then obtained the sequence 
of the individual thioredoxin, DsbA, DsbG and glutaredoxin orthologues present in these 
individual genomes using BLAST by searching with the E. coli homologue.
Plasmid construction and site-directed mutagenesis
The coding DNA sequence of the thioredoxin gene trxA, the N-domain of dsbD (G63D), and 
the thioredoxin reductase gene trxB were amplified from the genome of E. coli ER1821 (New 
England Biolabs) by PCR using the primers described in the supplemental materials and 
ligated into pQE60 (Qiagen) that had been cut with NcoI and BglII. Other constructs were 
from our lab strain collection. Point mutations were introduced into the WT dsbA gene in 
pXK22, dsbG in pAH232, and trxA in pR122 using a Stratagene Quick Change kit 
(Stratagene, La Jolla, CA) and appropriate mutagenic primers, and PCR was performed as 
directed. The product was digested with Dpn I, precipitated using Pelletpaint® according to 
the protocol supplied by the manufacturer (Novagen) (Dpn I), and resuspended in ~10 ml 
ddH2O. Five microliters of product was transformed into XL10-gold competent cells 
(Stratagene). DNA was extracted from the cells and all point mutations were verified by DNA 
sequencing. The coding DNA sequence of DsbC was PCR amplified from E. coli genomic 
DNA and cloned into the pET42b vector (Novagen, Madison, WI) using NdeI and XhoI 
restriction sites. 
Protein purification, reduction, oxidation, concentration determination,
WT DsbA and mutants were overexpressed in XK31 cells (BL21 dsbA::kan). His-tagged 
versions of WT DsbG, DsbC and their mutants were overexpressed in BL21 cells. WT 
thioredoxin and mutants, nDsbD and cDsbD, and thioredoxin reductase were overexpressed 
in M15 cells. WT DsbA and mutants were first purified from periplasmic extract using anion 
exchange (5 ml Q Sepharose Fast Flow). WT DsbG, DsbC and their mutants and WT 
thioredoxin and its mutants were first purified using a 6-His tag and nickel chromatography. 
Then, DsbA, DsbA V150T, DsbG, DsbG T200L, and thioredoxin I75T were further purified 
by size-exclusion using Superdex 75 chromatography. DsbC was further purified by size 
exclusion on Superdex S-200. All proteins were >95% pure as determined by Coomassie 
staining of SDS-PAGE gels. Scrambled hirudin and DsbB, prepared as previously described 
(4,5), were kindly provided by Shu Quan and Timothy Tapley, respectively.
DsbA, DsbG, thioredoxin, and their mutants were oxidized by incubation in 20 mM oxidized 
glutathione for 2 h at 4°C. DsbC and its mutant were oxidized with 1.7 mM 
copper(II)[1,10-phenanthroline]. DsbA, DsbG, thioredoxin, DsbC and their mutants and 
cDsbD were reduced by incubation with 10 mM DTT for 1 h at 4°C. The reactions were then 
desalted on NAP-5 columns (GE Healthcare) and the protein fractions were collected. Protein 
concentrations were determined by absorbance at 280 nm using extinction coefficients of 
23,045 and 22,920 cm-1M-1, respectively, for reduced and oxidized DsbA; 44,015 and 43,890 
cm-1M-1, respectively, for reduced and oxidized DsbG; 13,980, 14,105 cm-1M-1, respectively, 
for reduced and oxidized thioredoxin; and 17,670 and 17,420 cm-1M-1, respectively, for 
reduced and oxidized DsbC. Values for nDsbD, cDsbD and thioredoxin reductase were 
20,340, 8,370, and 19,000 cm-1M-1, respectively. These extinction coefficients were calculated 
using ExPASy (http://ca.expasy.org/). 
Isomerase activity assay
Scrambled RNase A as substrate
To determine the in vitro isomerase activity of DsbA V150T and DsbC T182V, we utilized the 
scrambled RNase A (scRNase A) refolding assay. Reduced denatured RNase A (0.5 mg/ml) 
was incubated in 50 mM Tris-HCl, pH 8.5, and 6 M GdmCl for at least 3 days in the dark at 
room temperature to prepare scRNase A (6). The randomly reoxidized RNase A was 
concentrated and, after the solution was acidified, the oxidation of disulfide bonds was 
confirmed using Ellman’s assay. Reshuffling of scRNase A (40 µM) was carried out by 
incubation in 100 mM phosphoric acid-NaOH, pH 7, 1 mM EDTA, with 10 µM oxidized 
DsbC, DsbCT182V, DsbA or DsbA V150T (DsbA, DsbC and mutants were oxidized with 1.7 
mM copper(II)[1,10-phenanthroline]). The reactions were initiated by the addition of DTT to 
a final concentration of 10 mM. As a positive control, we carried out an additional reaction 
using folded RNase A without any Dsb protein. The assay was performed at 25 ˚C, and 
samples were withdrawn at several time points and assayed for RNase A activity by 
monitoring cCMP hydrolysis spectrophotometrically at 296 nm for 2.5 min. The fraction of 
native RNase A (in %) was plotted against incubation time.
Kinetics of DsbG, and variants interaction with DsbD
The reduction of oxidized DsbG and variants by a stoichiometric amount of reduced cDsbD 
and a catalytic amount of nDsbD was peformed according to Collet et al. (7). One micromolar 
oxidized DsbG and 1 μM reduced cDsbD were mixed at room temperature (no change in 
fluorescence), and 10 nM nDsbD was added to initiate the reaction. Tryptophan excitation 
was monitored at 295 nm, and emission was monitored at 330 nm in a Hitachi F-4800 
spectrofluorometer. 
SUPPLEMENTAL TABLES
Table S1. Strains and plasmids used in the study
Strains Relevant genotype
BL21 E. coli B F– ompT hsdSB(rB – mB–) 
gal dcm (DE3)
XK31 BL21 DsbA::Kan
DHB4 F' lac-pro lacIQ/[ara-leu]7697 
araD139 lacX74 galE galK rpsL phoR 
(phoA) PvuII malF3 thi
AH435 DHB4 trxA null
M15 (pREP4) NalS strS rifS thi lac ara gal mtl F
recA+ uvr+ lon+ [pREP4 KanR]
Plasmids Vector and insert
pXK22 pET11a-DsbA
pAH232 pET28a-DsbG (His tagged)
pR122 pQE-Trx (His tagged)
pR130 pQE-nDsbD (G63D) (His tagged)
pJFC2 pQE-cDsbD (His tagged)
pR319 pQE-TrxR (His tagged)
Table S2. Redox potential of thioredoxin I75 mutants (mV)
Hydrophobic Polar
Large side chain Small side chain Not charged Aromatic Charged
I -271±1 A -256±0 Q -247±1 Y -221±1 K -242±1
L -270±1 S -235±1 W -219±4 R -240±0
M -262±1 N -231±1 H -258±1
F -259±4 T -226±1 E -246±1
V -257±1 D -245±1
No side chain effect G -250±0
Table S3. Data collection and refinement statistics
Thioredoxin (I75T)
Data collection
Wavelength 1.5418 Å
Space group C2
Unit cell (Å) a = 58.8 Å, b = 39.4 Å, c = 90.6 Å, b = 96.6°
Resolution (Å) 2.0
Completeness (%) 97.0 (94.7)
I / σ 20.7 (5.1)
Rmerge (%) 5.9 (24.9)
Redundancy 3.2
Unique reflections 13,739
Refinement  
Rwork/ Rfree 25.1/29.0
Rmsd, bonds (Å) 0.007
Rmsd, angles (°) 1.038
Mean B (Å2) 26.2
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